Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1900)
All Articles published online
|
Feb 28, 2007 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Famularo G, Miele L, Minisola G, Grieco A. Liver toxicity of rosuvastatin therapy. World J Gastroenterol 2007; 13(8): 1286-1288 [PMID: 17451217 DOI: 10.3748/wjg.v13.i8.1286] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i8/1286.htm |
| Number | Citing Articles |
| 1 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2007; 16(11) doi: 10.1002/pds.1377
|
| 2 |
Leon D. Averbukh, Alla Turshudzhyan, David C. Wu, George Y. Wu. Statin-induced Liver Injury Patterns: A Clinical Review. Journal of Clinical and Translational Hepatology 2022; 10(3): 543 doi: 10.14218/JCTH.2021.00271
|
| 3 |
Narci C. Teoh, Shivakumar Chitturi, Geoffrey C. Farrell. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2010; : 1413 doi: 10.1016/B978-1-4160-6189-2.00086-X
|
| 4 |
Katalin Jemnitz, Zsuzsa Veres, Regina Tugyi, Laszlo Vereczkey. Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes. Toxicology in Vitro 2010; 24(2): 605 doi: 10.1016/j.tiv.2009.10.009
|
| 5 |
Colin H. Beckwitt, Amanda M. Clark, Bo Ma, Diana Whaley, Zoltán N. Oltvai, Alan Wells. Statins attenuate outgrowth of breast cancer metastases. British Journal of Cancer 2018; 119(9): 1094 doi: 10.1038/s41416-018-0267-7
|
| 6 |
Lu Liu, Li Fu, Jin-Wei Zhang, Hui Wei, Wen-Ling Ye, Zhen-Ke Deng, Lin Zhang, Yan Cheng, Defang Ouyang, Qian Cao, Dong-Sheng Cao. Three-Level Hepatotoxicity Prediction System Based on Adverse Hepatic Effects. Molecular Pharmaceutics 2019; 16(1): 393 doi: 10.1021/acs.molpharmaceut.8b01048
|
| 7 |
Javed Ehtisham, Mario Altieri, Ephrem Salamé, Eric Saloux, Isabelle Ollivier, Martial Hamon. Coronary artery disease in orthotopic liver transplantation: Pretransplant assessment and management. Liver Transplantation 2010; 16(5): 550 doi: 10.1002/lt.22035
|
| 8 |
Marcel Zughaib. Do Cinnamon Supplements Cause Acute Hepatitis?. American Journal of Case Reports 2015; 16: 250 doi: 10.12659/AJCR.892804
|
| 9 |
Tao Yuan, Ruilin Wu, Weihua Wang, Yue Liu, Wencheng Kong, Bo Yang, Qiaojun He, Hong Zhu. Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1136114
|
| 10 |
Nuerbiye Tuerdi, Lu Xu, Baoling Zhu, Cong Chen, Yini Cao, Yunan Wang, Qiang Zhang, Zijian Li, Rong Qi. Preventive effects of simvastatin nanoliposome on isoproterenol-induced cardiac remodeling in mice. Nanomedicine: Nanotechnology, Biology and Medicine 2016; 12(7): 1899 doi: 10.1016/j.nano.2016.05.002
|
| 11 |
Guan‐Lin Chen, Fei‐Yuan Hsiao, Yaa‐Hui Dong, Li‐Jiuan Shen, Fe‐Lin Lin Wu. Statins and the risk of liver injury: a population‐based case‐control study. Pharmacoepidemiology and Drug Safety 2014; 23(7): 719 doi: 10.1002/pds.3646
|
| 12 |
Tarek A. Ahmed, Hanan Elimam, Alyaa O. Alrifai, Hebah M. Nadhrah, Lujain Y. Masoudi, Wed O. Sairafi, Khalid M. El-Say. Rosuvastatin lyophilized tablets loaded with flexible chitosomes for improved drug bioavailability, anti-hyperlipidemic and anti-oxidant activity. International Journal of Pharmaceutics 2020; 588: 119791 doi: 10.1016/j.ijpharm.2020.119791
|
| 13 |
Safaa M. Shaker, Hany K. Kamel, Samar M.F. Ezzat. The role of rosuvastatin in experimentally induced hepatic cholestasis in adult male albino rats. The Egyptian Journal of Histology 2015; 38(2): 219 doi: 10.1097/01.EHX.0000464733.26091.6b
|
| 14 |
Luis Díaz-Orozco, Fernando Quiroz-Compean, Jorge Aquino-Matus, Rolf Teschke, Nahum Méndez-Sánchez. Severe DILI in a Patient under Polypharmacy Including Rosuvastatin:
Diagnostic Challenges and Lessons from a Case Report Assessed Using the
Updated RUCAM Algorithm. The International Journal of Gastroenterology and Hepatology Diseases 2022; 1(1) doi: 10.2174/2666290601666220425104715
|
| 15 |
Jigneshkumar Vaghasiya, Satyam Patel, Sudhir Patel, Shekhar Kadam, Ramchandra Ranvir, Harilal Patel, Rajesh Sundar, Mukul Jain. Non-clinical safety evaluation of a novel pharmaceutical salt, rosuvastatin ethanolamine, in Wistar rats. Interdisciplinary Toxicology 2019; 12(1): 7 doi: 10.2478/intox-2019-0002
|
| 16 |
Chen Ning, Shengdi Su, Jiaming Li, Dexuan Kong, Hui Cai, Zhiying Qin, Han Xing, Xijing Chen, Jiake He. Evaluation of a Clinically Relevant Drug–Drug Interaction Between Rosuvastatin and Clopidogrel and the Risk of Hepatotoxicity. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.715577
|
| 17 |
Michael S. Kostapanos, Haralampos J. Milionis, Moses S. Elisaf. Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia. American Journal Cardiovascular Drugs 2010; 10(1): 11 doi: 10.2165/13168600-000000000-00000
|
| 18 |
Michele Ghielmetti, Helen Dorothea Schaufelberger, Giorgina Mieli-Vergani, Andreas Cerny, Eric Dayer, Diego Vergani, Benedetta Terziroli Beretta-Piccoli. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?. Journal of Autoimmunity 2021; 123: 102706 doi: 10.1016/j.jaut.2021.102706
|
| 19 |
Eszter Herczenik, Martijn F. B. G. Gebbink. Molecular and cellular aspects of protein misfolding and disease. The FASEB Journal 2008; 22(7): 2115 doi: 10.1096/fj.07-099671
|
| 20 |
Mónika Szabó, Zsuzsa Veres, Attila Bátai-Konczos, Orsolya Kékesi, Emese Kis, Kitti Szabó, Katalin Jemnitz. Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes. Toxicology in Vitro 2014; 28(6): 1136 doi: 10.1016/j.tiv.2014.05.016
|